JI
John Smith Clark II
10% Owner

John Smith Clark II insider trades: Fennec Pharmaceuticals (FENC) stock buys and sales

10% Owner, Fennec Pharmaceuticals Last trade Nov 18, 2025 12 Form 4 filings
$2.2M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2007
6
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 18, 2025FENC↓ Sell$170K
Nov 17, 2025FENC↓ Sell$2.0M
Oct 9, 2025FENC↓ Sell$636K
May 4, 2020FENC↑ Buy$500K
Aug 27, 2008NEXM↑ Buy$1.6M
Dec 4, 2007LEVP↓ Sell$2.1M
Sep 6, 2007IESC↓ Sell$41.8M
Mar 16, 2007LEVP↑ Buy$84K
Jan 8, 2007IESC↑ Buy$1.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other FENC insiders

Open-market trades in the last 12 months

About John Smith Clark II's insider trades

John Smith Clark II is a 10% owner of Fennec Pharmaceuticals (FENC). Since Jan 8, 2007, John has reported 4 open-market purchases worth $3.8M and 5 sales worth $46.7M on SEC Form 4. In the last 12 months: 2 sales ($2.2M).

Their filings also include other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FENC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.